SMART-SF Radiofrequency Ablation Safety Study

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 165 participants.

Also called NCT02359890

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 165 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02359890
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02359890. Allocation not applicable; no masking; primary purpose treatment. Start 2015-03-01 (actual); primary completion 2015-09-01 (actual). Results posted on 2017-10-17.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
SMART-SF Radiofrequency Ablation Safety Study
Intervention (Device)
THERMOCOOL® SMARTTOUCH® (RF ablation treatment)
Lead sponsor
Biosense Webster, Inc. (class: industry)

Record details

Record id
cardio:ct-nct02359890
Content hash
e52153e5c688f45987be45a26d882cb8694a9f71cb5b5d2fb6234a10bb50e3d2